Helen I Keen

Summary

Affiliation: University of Western Australia
Country: Australia

Publications

  1. doi request reprint Safety evaluation of leflunomide in rheumatoid arthritis
    Helen I Keen
    UWA, School of Medicine and Pharmacology, Perth WA, Australia
    Expert Opin Drug Saf 12:581-8. 2013
  2. doi request reprint A systematic review of ultrasonography in gout and asymptomatic hyperuricaemia
    Priya V Chowalloor
    Department of Rheumatology, Royal Perth Hospital, Perth, Western Australia, Australia
    Ann Rheum Dis 72:638-45. 2013
  3. doi request reprint A systematic review of ultrasonography in osteoarthritis
    H I Keen
    School of Medicine and Pharmacology, Royal Perth Hospital, Perth, WA, Western Australia
    Ann Rheum Dis 68:611-9. 2009

Collaborators

Detail Information

Publications3

  1. doi request reprint Safety evaluation of leflunomide in rheumatoid arthritis
    Helen I Keen
    UWA, School of Medicine and Pharmacology, Perth WA, Australia
    Expert Opin Drug Saf 12:581-8. 2013
    ..Leflunomide was developed as an immunomodulatory agent and subsequently developed as a disease-modifying anti-rheumatic drug (DMARD) for the management of rheumatoid arthritis (RA)...
  2. doi request reprint A systematic review of ultrasonography in gout and asymptomatic hyperuricaemia
    Priya V Chowalloor
    Department of Rheumatology, Royal Perth Hospital, Perth, Western Australia, Australia
    Ann Rheum Dis 72:638-45. 2013
    ..US is a promising tool which could be used in the diagnosis and management of gout. More studies are needed to assess responsiveness, reliability and feasibility...
  3. doi request reprint A systematic review of ultrasonography in osteoarthritis
    H I Keen
    School of Medicine and Pharmacology, Royal Perth Hospital, Perth, WA, Western Australia
    Ann Rheum Dis 68:611-9. 2009
    ..Aims: To undertake a systematic review of the published literature evaluating ultrasonography as an assessment tool in osteoarthritis...